AC
GSK icon

Alexandria Capital’s GSK GSK Stock Holding History

Alexandria Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-131
Closed -$7K – 581
2017
Q2 		$7K Buy
131
+1
+0.8% +$53 ﹤0.01% 458
2017
Q1 		$7K Buy
130
+2
+2% +$101 ﹤0.01% 454
2016
Q4 		$6K Hold
128
– – ﹤0.01% 460
2016
Q3 		$7K Hold
128
– – ﹤0.01% 455
2016
Q2 		$7K Sell
128
-432
-77% -$22.8K ﹤0.01% 451
2016
Q1 		$28K Buy
560
+7
+1% +$349 0.01% 309
2015
Q4 		$28K Buy
553
+8
+1% +$408 0.01% 322
2015
Q3 		$26K Buy
545
+8
+1% +$416 0.01% 297
2015
Q2 		$28K Sell
537
-738
-58% -$41.6K 0.01% 309
2015
Q1 		$74K Buy
1,275
+553
+77% +$31.7K 0.03% 166
2014
Q4 		$39K Buy
722
+10
+1% +$559 0.02% 221
2014
Q3 		$41K Buy
712
+72
+11% +$4.41K 0.02% 215
2014
Q2 		$43K Sell
640
-146
-19% -$9.88K 0.02% 216
2014
Q1 		$52K Hold
786
– – 0.02% 184
2013
Q4 		$52K Hold
786
– – 0.02% 191
2013
Q3 		$49K Sell
786
-240
-23% -$15.4K 0.02% 192
2013
Q2 		$64K Buy
+1,026
New +$65.1K 0.03% 170

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Alexandria Capital's GSK Position: Q3 2017 in Review

Alexandria Capital sold out of GSK (GSK) in Q3 2017, closing a stake of 131 shares — an estimated $7K sold.

Alexandria Capital first reported a position in GSK in Q2 2013 and held it in 17 quarters. The position peaked at $74K in Q1 2015. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Alexandria Capital reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Alexandria Capital sold 131 GSK shares in Q3 2017, an estimated $7K.
  • Alexandria Capital first reported a position in GSK in Q2 2013 and held it in 17 quarters.
  • Alexandria Capital's GSK position peaked at $74K in Q1 2015.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Alexandria Capital's 13F filing for Q3 2017, filed 27 Oct 2017.